Natera, Inc.

NASDAQ:NTRA

124.74 (USD) • At close October 29, 2024
Bedrijfsnaam Natera, Inc.
Symbool NTRA
Munteenheid USD
Prijs 124.74
Beurswaarde 15,427,967,940
Dividendpercentage 0%
52-weken bereik 37.665 - 133.539
Industrie Diagnostics & Research
Sector Healthcare
CEO Mr. Steven Leonard Chapman
Website https://www.natera.com

An error occurred while fetching data.

Over Natera, Inc.

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene

Vergelijkbare Aandelen

Merit Medical Systems, Inc. logo

Merit Medical Systems, Inc.

MMSI

95.9 USD

LivaNova PLC logo

LivaNova PLC

LIVN

52.97 USD

Surgery Partners, Inc. logo

Surgery Partners, Inc.

SGRY

30.06 USD

Arrowhead Pharmaceuticals, Inc. logo

Arrowhead Pharmaceuticals, Inc.

ARWR

19.98 USD

CureVac N.V. logo

CureVac N.V.

CVAC

2.89 USD

Novavax, Inc. logo

Novavax, Inc.

NVAX

10.07 USD

Blueprint Medicines Corporation logo

Blueprint Medicines Corporation

BPMC

83.4 USD

Cytokinetics, Incorporated logo

Cytokinetics, Incorporated

CYTK

51.51 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)